Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
105,227,688
-
Shares change
-
+1,034,170
-
Total reported value, excl. options
-
$661,832,362
-
Value change
-
+$7,044,227
-
Put/Call ratio
-
325%
-
Number of buys
-
39
-
Number of sells
-
46
-
Price
-
$6.29
Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2019
As of 30 Jun 2019 LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) had 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 105,227,688 shares of stock of the company.
Largest 10 holders included Artal Group S.A., FMR LLC, Ulys, L.L.C., VANGUARD GROUP INC, BlackRock Inc., FIRST MANHATTAN CO, NEA Management Company, LLC, Opaleye Management Inc., Clearbridge Investments, LLC, and UBS ASSET MANAGEMENT AMERICAS INC.
This table shows 138 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.